NCT01878435
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +30 more
- Locations
-
- Gem and Asembo Area Gem and Asembo Area, Siaya County, Kenya
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
720 public trials
60 recruiting studies
Hepatitis B trial results
NCT02434848
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
- Locations
-
- Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom
NCT04971928
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +11 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site San Antonio, Texas, United States
NCT01251276
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT01970254
- Conditions
- Blood-Borne Infections, Cancer, Communicable Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04723602
- Conditions
- Acquired Immunodeficiency Syndrome, Acquired angioedema, Angioedema, +64 more
- Locations
-
- Oklahoma Blood Institute (OBI) Oklahoma City, Oklahoma, United States
Completed
Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children
NCT04188223
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Hasan Sadikin Hospital Bandung, West Java, Indonesia
NCT04490499
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0009) Kokkola, Keski-Pohjanmaa, Finland
- Tampereen yliopisto Oulun rokotetutkimusklinikka ( Site 0004) Oulu, North Ostrobothnia, Finland
- Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001) Tampere, Pirkanmaa, Finland
- Seinajoki Vaccine Research Center ( Site 0010) Seinajoki, Pohjanmaa, Finland
NCT04531098
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- National Institute of Hygiene and Epidemiology (NIHE) Hanoi, Vietnam
Completed
Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
NCT04209400
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Saint Petersburg State Budgetary Healthcare Institution Saint Petersburg, Mirgorodskaya, Russia